MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
MacroGenics(MGNX) stock is priced at $3.39, giving the company a market capitalization of 215.14M. It carries a P/E multiple of -3.04.
On 2026-04-13, MacroGenics(MGNX) stock moved within a range of $3.36 to $3.62. With shares now at $3.39, the stock is trading +0.7% above its intraday low and -6.5% below the session's peak.
Trading activity shows a volume of 551.89K, compared to an average daily volume of 936.3K.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.88 and a low of $1.10.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.88 and a low of $1.10.
MGNX News
B. Riley upgraded MacroGenics (MGNX) to Buy from Neutral with a $9 price target. Following the Gilead (GILD) deal for Tubulus earlier this week, the firm put to...
B. Riley upgraded MacroGenics (MGNX) to Buy from Neutral with a $9 price target Published first on TheFly – the ultimate source for real-time, market-moving br...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
50%
of 6 ratingsMore MGNX News
MacroGenics (MGNX) announced that the U. S. FDA has removed the partial clinical hold on the company’s Phase 2 LINNET study of lorigerlimab, an investigational,...
The U.S. market has experienced a notable climb, rising 1.2% in the last week and 33% over the past year, with earnings projected to grow significantly in the c...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.